isopropyl-thiogalactoside and Osteosarcoma

isopropyl-thiogalactoside has been researched along with Osteosarcoma* in 2 studies

Other Studies

2 other study(ies) available for isopropyl-thiogalactoside and Osteosarcoma

ArticleYear
Limited role of N-terminal phosphoserine residues in the activation of transcription by p53.
    Oncogene, 2004, May-27, Volume: 23, Issue:25

    The p53 tumor suppressor is phosphorylated in response to various cellular stress signals, such as DNA damage, leading to its release from MDM2 and consequent stabilization and activation as a transcription factor. In human U2OS cells, treatment with adriamycin causes p53 to be phosphorylated on all six serine residues tested, leading to the dissociation of p53 from MDM2 and transcription of the p21 and mdm2 genes. In contrast, in these cells, IPTG-dependent induction of p14ARF, which sequesters MDM2 away from p53, does not lead to detectable phosphorylation of any of the five N-terminal serine residues tested (6, 9, 15, 20, 37). Only C-terminal serine 392 is phosphorylated. However, the increase of p21 and mdm2 mRNAs was indistinguishable following treatment with adriamycin or induction of p14ARF. By using cDNA arrays to examine global p53-dependent gene expression in response to adriamycin or p14ARF, we found that most genes were regulated similarly by the two treatments. However, a subset of p53-regulated genes whose products have proliferative roles or regulate VEGF activity, newly described here, are repressed by p14ARF much more than by adriamycin. We conclude that the phosphorylation of p53 on N-terminal serine residues is not required for increased transcription of the great majority of p53-responsive genes and that the induction of p53 by p14ARF, with little phosphorylation, leads to substantial repression of genes whose products have roles in proliferation.

    Topics: Bone Neoplasms; Cell Division; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA Damage; DNA, Complementary; Doxorubicin; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Isopropyl Thiogalactoside; Neoplasm Proteins; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Osteosarcoma; Phosphorylation; Phosphoserine; Protein Processing, Post-Translational; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Structure-Activity Relationship; Transcriptional Activation; Tumor Suppressor Protein p14ARF; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor A

2004
Cell transformation by c-fos requires an extended period of expression and is independent of the cell cycle.
    Molecular and cellular biology, 1994, Volume: 14, Issue:6

    The proto-oncogene transcription factors Fos and Jun form a heterodimeric complex that binds to DNA and regulates expression of specific target genes. Continuous expression of c-fos causes transformation of cultured fibroblasts and induces osteogenic sarcoma in mice. To investigate the molecular basis of fos-mediated oncogenesis, we developed a conditional cell transformation system in which Fos expression was regulated by isopropyl-beta-D-thiogalactopyranoside (IPTG). Synthesis or repression of Fos in L1-3c-fos cells occurred rapidly, within 30 min, after the removal or addition of IPTG to the culture medium. However, there was a significant delay between the induction of Fos expression and the appearance of morphological transformation. No effect was observed after 12 h of Fos expression, partial transformation was detected after 24 h, and full transformation required approximately 3 days of continuous Fos expression. Similarly, the transformed cell morphology persisted for at least 2 days after repression of Fos, and a normal phenotype was observed only after 3 days. Fos-Jun complexes, capable of binding to AP-1 sequences, were present continuously during the delay in morphological transformation. Furthermore, increased expression of several candidate Fos target genes, including those encoding Fra-1, transin (stromelysin), collagenase, and ornithine decarboxylase, was detected shortly after Fos induction. The induction of morphological transformation was not dependent on the cell cycle, as it occurred in both cycling and noncycling cells. Thus, the Fos-Jun complexes present before L1-3c-fos cells become fully transformed are transcriptionally active. These complexes disappeared, and the Fos target genes were repressed at least 2 days prior to reversion. Our results suggest that cell transformation by Fos requires increased expression of a target gene(s) with a long-lived product(s) that must reach a critical level.

    Topics: Animals; Bone Neoplasms; Cell Cycle; Cell Division; Cell Transformation, Neoplastic; Cells, Cultured; DNA-Binding Proteins; Fibroblasts; Gene Expression; Genes, fos; Isopropyl Thiogalactoside; Kinetics; Mice; Osteosarcoma; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Restriction Mapping; Time Factors; Transfection

1994